[Description and role of bacteriological techniques in the management of lung infections]
- PMID: 28688757
- PMCID: PMC7134997
- DOI: 10.1016/j.rmr.2016.07.007
[Description and role of bacteriological techniques in the management of lung infections]
Abstract
Acute pneumonias occur in a variety of clinical settings and accurate identification of bacterial causes is extremely important. No microbiological tool is either 100 % sensitive or 100 % specific, and despite investigations, aetiology remains unanswered in more than 30 % of pneumonia. No sample may be necessary for patients treated as outpatients, non invasive respiratory specimens are preferred in hospitalised individuals (community or healthcare associated), while invasive specimens are used as second line for community acquired pneumonia (CAP) in intensive care, and in the first line where pneumonia occurs in immunosuppressed patients. Bacterial cultures have an important place, if the sample is taken before the introduction of antibiotic therapy. Some contexts may justify the use of blood cultures, testing for urinary antigens or serology. PCR is already becoming available as a daily service but the short-term future probably belongs to molecular multiplex panels capable of detecting many microorganisms within hours, especially in severe CAP resuscitation and in pneumonia in the immunosuppressed. High-throughput sequencing nucleotide techniques will soon revolutionize microbiological diagnosis in respiratory medicine, as in other areas of infectious diseases.
Les pneumopathies aiguës recouvrent des contextes cliniques variés et les étiologies bactériennes impliquées le sont tout autant. Aucun outil microbiologique n’est 100 % sensible ni 100 % spécifique et malgré les investigations, plus de 30 % des pneumopathies restent sans étiologie identifiée. Si aucun prélèvement n’est indiqué pour les patients traités en ambulatoire, les prélèvements respiratoires non invasifs sont à privilégier pour les pneumopathies aiguës hospitalisées (communautaires ou associées aux soins), tandis que les prélèvements invasifs sont indiqués en seconde ligne pour les pneumopathies aiguës communautaires en réanimation, et en première ligne pour les pneumopathies aiguës de l’immunodéprimé. La culture microbiologique garde une place importante, à condition que le malade soit prélevé avant instauration de l’antibiothérapie. Certains contextes peuvent justifier le recours aux hémocultures, à la recherche d’antigènes urinaires ou aux sérologies. Les PCR rendent déjà service au quotidien mais l’avenir à court terme appartient probablement aux panels moléculaires multiplex capables de détecter de nombreux micro-organismes en quelques heures, surtout dans les pneumopathies communautaires sévères de réanimation et les pneumopathies aiguës de l’immunodéprimé. Le séquençage nucléotidique haut débit révolutionnera bientôt le diagnostic microbiologique, en pneumologie comme dans les autres domaines de l’infectiologie.
Keywords: Diagnostic bactériologique; Diagnostic serology; Microbiological diagnosis; PCR; Pneumonia; Pneumopathie; Prélèvements respiratoires; Respiratory sampling; Sérologie.
Copyright © 2017 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
Detection of respiratory bacterial pathogens causing atypical pneumonia by multiplex Lightmix® RT-PCR.Int J Med Microbiol. 2018 Apr;308(3):317-323. doi: 10.1016/j.ijmm.2018.01.010. Epub 2018 Jan 31. Int J Med Microbiol. 2018. PMID: 29397298
-
The use of multiplex real-time PCR improves the detection of the bacterial etiology of community acquired pneumonia.Trop Biomed. 2011 Dec;28(3):531-44. Trop Biomed. 2011. PMID: 22433882
-
[Diagnostic work-up in community-acquired pneumonia].MMW Fortschr Med. 2010 Nov 11;152(45):35-7. doi: 10.1007/BF03367375. MMW Fortschr Med. 2010. PMID: 21319407 German. No abstract available.
-
Diagnostic tests for agents of community-acquired pneumonia.Clin Infect Dis. 2011 May;52 Suppl 4:S296-304. doi: 10.1093/cid/cir045. Clin Infect Dis. 2011. PMID: 21460288 Review.
-
[Microbiological diagnosis of community-acquired pneumopathies].Med Mal Infect. 2011 Jan;41(1 Suppl 1):H2-4. doi: 10.1016/S0399-077X(11)70002-6. Med Mal Infect. 2011. PMID: 21335251 Review. French. No abstract available.
Cited by
-
Application of mNGS in the study of pulmonary microbiome in pneumoconiosis complicated with pulmonary infection patients and exploration of potential biomarkers.Front Cell Infect Microbiol. 2023 Jul 21;13:1200157. doi: 10.3389/fcimb.2023.1200157. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37545858 Free PMC article.
-
Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study.Ann Intensive Care. 2022 Sep 30;12(1):90. doi: 10.1186/s13613-022-01059-9. Ann Intensive Care. 2022. PMID: 36175707 Free PMC article.
References
-
- Grgurich P.E., Hudcova J., Lei Y. Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr Opin Infect Dis. 2013;26:140–150. - PubMed
-
- Bergot E. Épidemiologie et mécanismes des pneumonies de l’adulte. Rev Prat. 2011;61:1064–1067. - PubMed
-
- Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867–903. - PubMed
-
- Waterer G.W., Rello J., Wunderink R.G. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med. 2011;183:157–164. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous